Judith earned her PhD studying the genetic background of autism, then led a research group that focused on mutations linked to cancer and epilepsy, using viral transduction to genetically modify cells. At Bielefeld University, she supported virus-based projects as the lead scientist for BSL2. Since 2019, she’s been a senior advisor at Körber Pharma Software, where she helps ATMP manufacturers move from paper to digital, build their digital ecosystem roadmaps, and develop holistic process model data concepts.